Spatial and temporal coordination of bone marrow-derived cell activity during arteriogenesis: regulation of the

Joshua K Meisner1, Richard J Price

  • 1Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA.

Microcirculation (New York, N.Y. : 1994)
|November 4, 2010
PubMed

Insights

Therapeutic arteriogenesis for arterial occlusive disease faces challenges due to poorly understood bone marrow-derived cell (BMC) interactions. This study reveals specific BMC populations and their roles in promoting collateral vessel development for targeted therapies.

Area of Science:

  • Cardiovascular Biology
  • Hematology
  • Regenerative Medicine

Background:

  • Arterial occlusive disease presents a major health burden, necessitating novel therapeutic strategies.
  • Therapeutic arteriogenesis shows promise but has faced clinical trial limitations.
  • The complex interplay between bone marrow-derived cells (BMCs) and vascular cells in arteriogenesis is not fully understood.

Purpose of the Study:

  • To elucidate the sequential roles of diverse bone marrow-derived cell populations in arteriogenesis.
  • To propose a framework for understanding BMC contributions to collateral vessel formation.
  • To identify specific BMC populations and functions for targeted therapeutic intervention.

Main Methods:

  • Review and synthesis of existing evidence on BMC involvement in arteriogenesis.
  • Analysis of cellular interactions and temporal recruitment patterns.
  • Hypothesizing the functional integration of different BMC subsets.

Main Results:

  • Arteriogenesis involves a precisely ordered sequence of BMC recruitment, including neutrophils, mast cells, and progenitor cells.
  • Specific BMC populations are critical at distinct stages and locations within the arteriogenesis process.
  • Impairments in distinct BMC populations correlate with specific patterns of arteriogenesis failure.

Conclusions:

  • Understanding arteriogenesis as a system with distinct BMC roles is key to therapeutic success.
  • Targeting specific BMC populations can overcome impairments in collateral vessel development.
  • This framework facilitates the design of more effective therapies for arterial occlusive disease.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...